Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Stock-Based Compensation history
Currency unavailable · from the cash flow
No Stock-Based Compensation data reported for this period type.
Stock-Based Compensation vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $96.8M USD | -5.7% | +32.9% | 136.4% | |
| LTM Jun 2026 | $33.39M USD | -16.1% | +143.5% | 468.9% | |
| LTM Mar 2026 | $18.83M USD | +85.9% | +222.1% | — | |
| LTM Mar 2026 | $11.51M USD | -28.1% | +4.4% | 5116.0% | |
| FY2025 | $7.68M USD | — | — | 41.2% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -10.9% | +88.2% | 302.7% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.